Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 17, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

21.2K

"For the Times They are a-Changin" Bob Dylan 1964

Kirk Barber

    Journal of Cutaneous Medicine and Surgery
    |September 18, 2025
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
    07:51

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

    Published on: June 1, 2019

    21.2K

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    2025: A Very Good Year for <i>JCMS</i>.

    Journal of cutaneous medicine and surgery·2026
    Same author

    101<sup>st</sup> CDA Annual Conference-Calgary, AB.

    Journal of cutaneous medicine and surgery·2026
    Same author

    <i>JCMS</i> 2025 Editorial Board Meeting.

    Journal of cutaneous medicine and surgery·2026
    Same author

    Visual Dermatology: Our Storybook.

    Journal of cutaneous medicine and surgery·2026
    Same author

    <i>JCMS</i>: Trust and the "Socials".

    Journal of cutaneous medicine and surgery·2025
    Same author

    Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2025